187 related articles for article (PubMed ID: 18300817)
1. Laminin 5 expression in metaplastic breast carcinomas.
Carpenter PM; Wang-Rodriguez J; Chan OT; Wilczynski SP
Am J Surg Pathol; 2008 Mar; 32(3):345-53. PubMed ID: 18300817
[TBL] [Abstract][Full Text] [Related]
2. Metaplastic breast carcinomas and their relationship with basal-like phenotype.
Cakir A; Gönül II; Uluoğlu O
Turk Patoloji Derg; 2012; 28(2):134-41. PubMed ID: 22627631
[TBL] [Abstract][Full Text] [Related]
3. Expression of p40 and laminin 332 in metaplastic spindle cell carcinoma of the breast compared with other malignant spindle cell tumours.
D'Alfonso TM; Ross DS; Liu YF; Shin SJ
J Clin Pathol; 2015 Jul; 68(7):516-21. PubMed ID: 25795733
[TBL] [Abstract][Full Text] [Related]
4. Metaplastic breast carcinoma: pathology and clinical outcome.
Bellino R; Arisio R; D'Addato F; Attini R; Durando A; Danese S; Bertone E; Grio R; Massobrio M
Anticancer Res; 2003; 23(1B):669-73. PubMed ID: 12680165
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic utility of snail in metaplastic breast carcinoma.
Nassar A; Sookhan N; Santisteban M; Bryant SC; Boughey JC; Giorgadze T; Degnim A
Diagn Pathol; 2010 Nov; 5():76. PubMed ID: 21110878
[TBL] [Abstract][Full Text] [Related]
6. Differential immunohistochemical and biological profile of squamous cell carcinoma of the breast.
Grenier J; Soria JC; Mathieu MC; Andre F; Abdelmoula S; Velasco V; Morat L; Besse B; Dunant A; Spielmann M; Delaloge S
Anticancer Res; 2007; 27(1B):547-55. PubMed ID: 17348440
[TBL] [Abstract][Full Text] [Related]
7. The majority of triple-negative breast cancer may correspond to basal-like carcinoma, but triple-negative breast cancer is not identical to basal-like carcinoma.
Kuroda N; Ohara M; Inoue K; Mizuno K; Fujishima N; Hamaguchi N; Lee GH
Med Mol Morphol; 2009 Jun; 42(2):128-31. PubMed ID: 19536621
[TBL] [Abstract][Full Text] [Related]
8. Basal-like immunophenotype markers and prognosis in early breast cancer.
Cassol L; Silveira Graudenz M; Zelmanowicz A; Cancela A; Werutsky G; Rovere RK; Garicochea B
Tumori; 2010; 96(6):966-70. PubMed ID: 21388060
[TBL] [Abstract][Full Text] [Related]
9. Metaplastic breast carcinomas display genomic and transcriptomic heterogeneity [corrected].
Weigelt B; Ng CK; Shen R; Popova T; Schizas M; Natrajan R; Mariani O; Stern MH; Norton L; Vincent-Salomon A; Reis-Filho JS
Mod Pathol; 2015 Mar; 28(3):340-51. PubMed ID: 25412848
[TBL] [Abstract][Full Text] [Related]
10. Metaplastic Carcinoma of the Breast: Analysis of 38 Cases from a Single Institute.
Hasbay B; Bolat FA; Aytaç HÖ; Aslan H; Purbager A
Turk Patoloji Derg; 2020; 36(1):23-30. PubMed ID: 31769499
[TBL] [Abstract][Full Text] [Related]
11. p63 is useful in the diagnosis of mammary metaplastic carcinomas.
Tse GM; Tan PH; Chaiwun B; Putti TC; Lui PC; Tsang AK; Wong FC; Lo AW
Pathology; 2006 Feb; 38(1):16-20. PubMed ID: 16484002
[TBL] [Abstract][Full Text] [Related]
12. Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma.
Livasy CA; Karaca G; Nanda R; Tretiakova MS; Olopade OI; Moore DT; Perou CM
Mod Pathol; 2006 Feb; 19(2):264-71. PubMed ID: 16341146
[TBL] [Abstract][Full Text] [Related]
13. p63 expression in breast cancer: a highly sensitive and specific marker of metaplastic carcinoma.
Koker MM; Kleer CG
Am J Surg Pathol; 2004 Nov; 28(11):1506-12. PubMed ID: 15489655
[TBL] [Abstract][Full Text] [Related]
14. [Basal and myoepithelial phenotype of metastatic mammary carcinomas. A prognostic factor in the palliative situation?].
Mainka P; Kahlert S; Kirchner T; Mayr D; Diebold J
Pathologe; 2008 Nov; 29 Suppl 2():363-9. PubMed ID: 18807040
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological features of metaplastic breast carcinoma.
Hasdemir OA; Tokgöz S; Köybaşıoğlu F; Karabacak H; Yücesoy C; İmamoğlu Gİ
Adv Clin Exp Med; 2018 Apr; 27(4):509-513. PubMed ID: 29558027
[TBL] [Abstract][Full Text] [Related]
16. Laminin-5 is a marker of invading cancer cells in some human carcinomas and is coexpressed with the receptor for urokinase plasminogen activator in budding cancer cells in colon adenocarcinomas.
Pyke C; Salo S; Ralfkiaer E; Rømer J; Danø K; Tryggvason K
Cancer Res; 1995 Sep; 55(18):4132-9. PubMed ID: 7664291
[TBL] [Abstract][Full Text] [Related]
17. Laminin 332 expression in breast carcinoma.
Kwon SY; Chae SW; Wilczynski SP; Arain A; Carpenter ; Philip M
Appl Immunohistochem Mol Morphol; 2012 Mar; 20(2):159-64. PubMed ID: 22427740
[TBL] [Abstract][Full Text] [Related]
18. Metaplastic breast carcinomas: are they of myoepithelial differentiation?: immunohistochemical profile of the sarcomatoid subtype using novel myoepithelial markers.
Leibl S; Gogg-Kammerer M; Sommersacher A; Denk H; Moinfar F
Am J Surg Pathol; 2005 Mar; 29(3):347-53. PubMed ID: 15725803
[TBL] [Abstract][Full Text] [Related]
19. [Matrix-producing breast carcinoma with myoepithelial differentiation--description of 11 cases and review of literature aimed at histogenesis and differential diagnosis].
Kinkor Z; Boudová L; Ryska A; Kajo K; Svec A
Ceska Gynekol; 2004 May; 69(3):229-36. PubMed ID: 15310000
[TBL] [Abstract][Full Text] [Related]
20. Increased alpha-B-crystallin expression in mammary metaplastic carcinomas.
Chan SK; Lui PC; Tan PH; Yamaguchi R; Moriya T; Yu AM; Shao MM; Hliang T; Wong SI; Tse GM
Histopathology; 2011 Aug; 59(2):247-55. PubMed ID: 21884203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
